The exact mechanism of lorlatinib causing hyperglycemia is currently unclear; however, it is known that the ALK gene is part of the insulin receptor protein-tyrosine kinase receptor super family and can structurally mimic insulin receptors. This evidence concerns the gene ALK and Hyperglycemia.